OVA (257 - 264) - 成都凯捷生物医药科技发展有限公司

Catalog Products

ADP-Ribosylation Factors (ARF)

Adrenomedullin Peptides

Agouti Related Peptides

Amylin Peptides

Amyloid Peptides

Angiotensins and Related Peptides

Annexin

Anti-Inflammatory Peptides

Antimicrobial and Related Peptides

Antioxidant Peptides

Apelin Peptides

Apolipoprotein Peptides

Apoptosis Peptides

Arg-Phe-Amide RFamide Related Peptides

Bacterial Peptides

Basic Fibroblast Growth Factor (bFGF)

Bcl / BAD Peptides

Bombesins

Bradykinins

C-Peptides

C3a Peptides

Calcitonin Related Peptides

Cancer Research Peptides

Cardiac Peptides

CART (Cocaine- and Amphetamine-Regulated Transcript) Peptides

Casomorphin Peptides

Caspase Related Peptides

CEF Control Peptides

Cell Adhesion Peptides

Cell Permeable Peptides (CPP) / Drug Delivery Peptides

Chemotaxis Peptides

Cholecystokinin-Pancreozymin Peptides

ClearPoint™-Heavy Isotope Labeled and Related Peptides

Corticotropin Related Peptides

Cyclic Peptides

Cytochromes and Related Peptides

Defensins

Deltorphin Peptides

Dynorphin Peptides

Endorphin Peptides

Endothelins

Enkephalins

Enzyme Substrates and Inhibitors

Exendins

Extracellular Matrix

Fibrinogen and Related Peptides

Fibronectin Fragments

Fluorescent Labeled Peptides

FRET Peptides

Galanins

Gastric Inhibitory Peptides (GIPs)

Gastrins

Ghrelins and Obestatins

Glucagon-Like Peptides

Glycopeptides

GPCR Peptide Ligands

Growth Factors

Growth Hormone Related Peptides

Hepatitis C Virus (HCV) Related Peptides

Histones

Guanylins

HIV Related Peptides

Hydrocarbon-Stapled Peptides

Integrins

Ion Channel Peptides

Kinases/Phosphatase Substrates

Luteinizing Hormone-Releasing Hormones and Related Peptides

MAPS Peptides

Matrix Metalloproteinases (MMPs)

Melan-A and Mucin Related Peptides

Melanocyte Stimulating Hormones and Analogs

MHC related

Microbial Peptides

Milk Peptides

Myelin Oligodendrocyte Glycoprotein (MOG)/Myelin Basic Proteins (MBP)

Myosin

Natriuretic Peptides

Neurokinins

Neuromedins

Neuropeptide Y and Analogs

Neuropeptides

Neurotensins and Related Peptides

NF-kB/Transcription Factors Related Peptides

Opioid Related Peptides

Orexins

Osteocalcin Fragments

OVA Peptides

Oxytocins, Vasopressins, and Related Peptides

p53 Peptides

Pancreatic Polypeptides

Parathyroid Hormones and Related Peptides

Peptide Aminoluciferin Custom Synthesis For Bioluminescent Assays

Peptide Standards

Peptide YY and Analogs

Peptidoglycan Peptides

Phagocytosis

Phosphopeptides

Phytochelatins

Pituitary Adenylate Cyclase Activating Peptides (PACAPS)

Prion Protein (PrP) Fragments

Prolactin Releasing Peptides

Protease Inhibitors

Protein Phosphorylation Related Peptides

Proteolipid Proteins (PLPs)

QA-GSH

Renin

Retinoid Binding Protein

RGD Peptides

Saposin Related Peptides

Secretins

Selectin Related Peptides

Signal Transduction Peptides

Somatostatins

Substance P and Analogs

Tag Peptides

Tau Peptides

Temporins

Thrombin Related Peptides

Thrombospondins

Thyrotropin Releasing Hormones and Related Peptides

Toxins

Tubulin Peptides

Urotensin related peptides

Vasoactive Intestinal Peptides (VIPs)

Viral Peptides

您的位置：主页 > Catalog Products > 目录肽 > 研发肽 > OVA Peptides

Product	OVA (257 - 264) SIINFEKL
CAS
Size	5 mg
Catalog #	60193-5
US$	198
Hits

Purity	% Peak Area By HPLC ≥ 95%
Description	This is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
Detailed Information	Datasheet
Storage	-20°C
References	Werlen, G. et al. Nature 406, 422 (2000); Maecker, H. et al. J. Immunol. 161, 6532 (1998).
Molecular Weight	963.2
Sequence (One-Letter Code)	SIINFEKL
Sequence (Three-Letter Code)	H - Ser - Ile - Ile - Asn - Phe - Glu - Lys - Leu - OH
Product Citations	Faisal, S. et al. (2011). Immunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses. Vaccine 10.1016/j.vaccine.2011.01.110. Lyszkiewicz, M. et al. (2011). SIGN-R1+MHC II+ cells of the splenic marginal zone—a novel type of resident dendritic cells. J Leukocyte Biol 89, 607. Yanasarn, N. et al. (2011). Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens. Mol Pharm 8, 1174. Durgan, K. et al. (2010). Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model. Cancer Immunol Immunotherapy 10.1007/s00262-010-0963-5. Fletcher, A. et al. (2010). Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions JEM 207, 689. Kelly, R. et al. (2010). Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation. Blood 115, 1088. Ordaz, M. et al. (2010). DC-expressed MHC class I single-chain trimer-based vaccines prime cytotoxic T lymphocytes against exogenous but not endogenous antigens. Cell Immunol 262, 141. Sun X. et al. (2010). Enhanced in vivo gene expression mediated by listeriolysin o incorporated anionic LPDII: Its utility in cytotoxic T lymphocyte-inducing DNA vaccine. J Control Release 10.1016/j.jconrel.2010.06.017. Nakayama, M. et al. (2009). Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113, 3821. Peng, Y. et al. (2009). Ly6Clow monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1. Blood 182, 2777. Qu, C. et al. (2009). MHC class I/peptide transfer between dendritic cells overcome poor cross-presentation by monocyte-derived APCs that engulf dying cells. J Immunol 182, 3650. Kelly, RM. et al. (2008). Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation. Blood 111, 5734. Towne, CF. et al. (2008). Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections. J Immunol 180, 1704. Kislin, KL. et al. (2007). Chaperone-rich cell lysate embedded with BCR-ABL peptide demonstrates enhanced anti-tumor activity against a murine BCR-ABL positive leukemia. FASEB J 21, 2173. Sato, N. et al. (2007). The IL-15/IL-15R on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. PNAS 104, 588. Cante-Barnett, K. et al. (2006). Thymocyte negative selection is mediated by protein kinase C-and Ca2+ -dependent transcriptional induction of Bim. J Immunol 176, 2299. Ren, Y. et al. (2006). OVA-specific CD8+T cells do not express granzyme B during anterior chamber associated immune deviation. Graefe's ARch Clin Exp Ophthalmol 244, 1315. Galibert, L. et al. (2005). Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J Biol Chem 280, 21955. Komlosh, A. et al. (2001). A role for a novel luminal endoplasmic reticulum aminopeptidase in final trimming of 26 S proteasome-generated major histocompatability complex class I antigenic peptides. J Biol Chem 276, 30050. Ben-Shahar, S. et al. (1999). 26 S proteasome-mediated production of an authentic major histocompatibility classI-restricted epitope from an intact protein substrate. J Biol Chem 274, 21963. Ben-Shahar, S. et al. (1997). Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysate. J Biol Chem 272, 21060.